1,143 research outputs found

    Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications

    Get PDF
    Conjugation of ubiquitin to proteins (ubiquitylation) has emerged to be one of the most crucial post-translational modifications controlling virtually all cellular processes. What was once regarded as a mere signal for protein degradation has turned out to be a major regulator of molecular signalling networks. Deregulation of ubiquitin signalling is closely associated with various human pathologies. Here, we summarize the current knowledge of ubiquitin signalling in immune deficiencies and cancer as well as the available therapeutic strategies targeting the ubiquitin system in combating these pathogenic conditions

    Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications

    Get PDF
    Conjugation of ubiquitin to proteins (ubiquitylation) has emerged to be one of the most crucial post-translational modifications controlling virtually all cellular processes. What was once regarded as a mere signal for protein degradation has turned out to be a major regulator of molecular signalling networks. Deregulation of ubiquitin signalling is closely associated with various human pathologies. Here, we summarize the current knowledge of ubiquitin signalling in immune deficiencies and cancer as well as the available therapeutic strategies targeting the ubiquitin system in combating these pathogenic conditions

    IAPs as E3 ligases of Rac1 : shaping the move

    Get PDF
    Inhibitors of Apoptosis Proteins (IAPs) are well-studied E3 ubiquitin ligases predominantly known for regulation of apoptosis. We uncovered that IAPs can function as a direct E3 ubiquitin ligase of RhoGTPase Rac1. cIAP1 and XIAP directly conjugate polyubiquitin chains to Lysine 147 of activated Rac1 and target it for proteasomal degradation. Consistently, loss of these IAPs by various strategies led to stabilization of Rac1 and mesenchymal mode of migration in tumor cells. IAPs also regulate Rac1 degradation upon RhoGDI1 depletion and CNF1 toxin treatment. Our observations revealed an evolutionarily conserved role of IAPs in regulating Rac1 stability shedding light on to the mechanisms behind ubiquitination–dependent inactivation of Rac1 signaling

    IAPs on the move : role of inhibitors of apoptosis proteins in cell migration

    Get PDF
    Inhibitors of Apoptosis Proteins (IAPs) are a class of highly conserved proteins predominantly known for the regulation of caspases and immune signaling. However, recent evidence suggests a crucial role for these molecules in the regulation of tumor cell shape and migration by controlling MAPK, NF-κB and Rho GTPases. IAPs directly control Rho GTPases, thus regulating cell shape and migration. For instance, XIAP and cIAP1 function as the direct E3 ubiquitin ligases of Rac1 and target it for proteasomal degradation. IAPs are differentially expressed in tumor cells and have been targeted by several cancer therapeutic drugs that are currently in clinical trials. Here, we summarize the current knowledge on the role of IAPs in the regulation of cell migration and discuss the possible implications of these observations in regulating tumor cell metastases

    Robust Part Quality by Controlling the Injection Moulding Process with 24 Fraction Factorial Design: A Case Study

    Get PDF
    The author wants to use a case study to investigate the injection moulding machine parameters which will affect the horizontal length dimension of a plastic component used in digital camera. Currently the injection moulding machine process setting caused variations in the diameter exceeding the specification limit. Therefore the experiment is needed to identify the process factors that could be set to maintain the horizontal length dimension closest to the target value and smallest possible variation. The experimental model is used to investigate four factors to identify the factors having large effect by using the Full Factorial Design of Experiment (DOE). The experiment has emphasized the use of these designs in identifying the subset of factors that are active and provide some information about the interaction

    Human diversity of killer cell immunoglobulin-like receptors and disease

    Get PDF
    Natural Killer (NK) cells are the third population of lymphocyte in the mononuclear cell compartment that triggers first-line of defense against viral infection and tumor transformation. Historically, NK cells were thought of as components of innate immunity based on their intrinsic ability to spontaneously kill target cells independent of HLA antigen restriction. However, it is now clear that NK cells are quite sophisticated and use a highly specific and complex target cell recognition receptor system arbitrated via a multitude of inhibitory and activating receptors. Killer cell immunoglobulin-like receptors (KIR) are the key receptors of human NK cells development and function. To date, fourteen distinct KIRs have been identified: eight are inhibitory types, and six are activating types. The number and type of KIR genes present varies substantially between individuals. Inhibitory KIRs recognize distinct motifs of polymorphic HLA class I molecules. Upon engagement of their specific HLA class I ligands, inhibitory KIR dampen NK cell reactivity. In contrast, activating KIRs are believed to stimulate NK cell reactivity when they sense their ligands (unknown). KIR and HLA gene families map to different human chromosomes (19 and 6, respectively), and their independent segregation produces a wide diversity in the number and type of inherited KIR-HLA combinations, likely contributing to overall immune competency. Consistent with this hypothesis, certain combinations of KIR-HLA variants have been correlated with susceptibility to diseases as diverse as autoimmunity, viral infections, and cancer. This review summarizes our emerging understanding of KIR-HLA diversity in human health and disease

    A Study on Injection Moulding and Injection Blow Molding Technology

    Get PDF
    Injection moulding and blow moulding are probably the most widely used process for manufacturing parts by using plastic materials. A wide variety of products are manufactured by using these two technologies, which vary greatly in their size, complexity, and application. The injection moulding process requires the use of an injection moulding machine, raw plastic material and a mould. The process cycle for injection moulding consists of the following four stages: clamping, injection, cooling and ejection. Blow moulding is a manufacturing process that is used to create hollow plastic parts by inflating a heated plastic tube until it fills a mould and forms the desired shape. The manufacturing process is divided into three stages: injection, blowing and ejection. There are many types of materials that may be used in the injection moulding and blow moulding process. Most polymers may be used, including all thermoplastics, some thermosets, and some elastomers.Injection moulding industry is used to create many things such as milk cartons, packaging, bottle caps, automotive dashboards, pocket combs, and most other plastic products available today. Parts made from blow moulding are plastic, hollow, and thin-walled, such as bottles and containers that are available in a variety of shapes and sizes. These study is about the process, equipments, materials and applications involve injection moulding and blow moulding technology. At the same time it’s also discuss about the advantage and disadvantage of both manufacturing technology

    Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells

    Get PDF
    As inhibitor of apoptosis (IAP) proteins can regulate additional signaling pathways beyond apoptosis, we investigated the effect of the second mitochondrial activator of caspases (Smac) mimetic BV6, which antagonizes IAP proteins, on non-apoptotic functions in glioblastoma (GBM). Here, we identify non-canonical nuclear factor-κB (NF-κB) signaling and a tumor necrosis factor-α (TNFα)/TNF receptor 1 (TNFR1) autocrine/paracrine loop as critical mediators of BV6-stimulated migration and invasion of GBM cells. In addition to GBM cell lines, BV6 triggers cell elongation, migration and invasion in primary, patient-derived GBM cells at non-toxic concentrations, which do not affect cell viability or proliferation, and also increases infiltrative tumor growth in vivo underscoring the relevance of these findings. Molecular studies reveal that BV6 causes rapid degradation of cellular IAP proteins, accumulation of NIK, processing of p100 to p52, translocation of p52 into the nucleus, increased NF-κB DNA binding and enhanced NF-κB transcriptional activity. Electrophoretic mobility shift assay supershift shows that the NF-κB DNA-binding subunits consist of p50, p52 and RelB further confirming the activation of the non-canonical NF-κB pathway. BV6-stimulated NF-κB activation leads to elevated mRNA levels of TNFα and additional NF-κB target genes involved in migration (i.e., interleukin 8, monocyte chemoattractant protein 1, CXC chemokine receptor 4) and invasion (i.e., matrix metalloproteinase-9). Importantly, inhibition of NF-κB by overexpression of dominant-negative IκBα superrepressor prevents the BV6-stimulated cell elongation, migration and invasion. Similarly, specific inhibition of non-canonical NF-κB signaling by RNA interference-mediated silencing of NIK suppresses the BV6-induced cell elongation, migration and invasion as well as upregulation of NF-κB target genes. Intriguingly, pharmacological or genetic inhibition of the BV6-stimulated TNFα autocrine/paracrine loop by the TNFα-blocking antibody Enbrel or by knockdown of TNFR1 abrogates BV6-induced cell elongation, migration and invasion. By demonstrating that the Smac mimetic BV6 at non-toxic concentrations promotes migration and invasion of GBM cells via non-canonical NF-κB signaling, our findings have important implications for the use of Smac mimetics as cancer therapeutics

    Finding the Correlation between Formative and Summative Assessments by Spearman’s Correlation Coefficient: A Case Study

    Get PDF
    Academic progresses of students are measured by using variety of statistical analysis techniques like central tendency, variability, percentiles and others. These measures help the teaching professionals to understand their student progress in their class. A relatively simple technique that can be used for exploratory data analysis is the Spearman rank correlation coefficient. In this paper the authors describe how the Spearman rank correlation coefficient can be used as a statistical tool to find out the correlation between two different types of assessments for a mathematics unit as a case study. This method is perhaps the simplest method for calculation of coefficient correlation. Is a non parametric technique for evaluating the degree of linear association or correlation between two independent variables. It is operates on the ranks of the data rather than the raw data. The case study result show that existence of a positive correlation of medium order between the formative and summative assessments. That is, increase in formative assessment the summative assessment also increase. In other words, some students who scored high in the formative assessment only managed to get medium scores in the summative assessment and vice versa
    corecore